EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS177-20273 
Organism
Homo sapiens 
Tissue/cell
SK-N-SH_RA 
Coordinate
chr7:2121620-2122550 
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EN2MA0642.1chr7:2122367-2122377CCCAATTAGC+6.02
EWSR1-FLI1MA0149.1chr7:2121903-2121921GGAGGGAGGGAAGGGAAG+6.33
EWSR1-FLI1MA0149.1chr7:2121793-2121811GGAAGGGAGGCAGGAGGG+7.6
EWSR1-FLI1MA0149.1chr7:2121899-2121917GGAAGGAGGGAGGGAAGG+8.15
ZNF263MA0528.1chr7:2121798-2121819GGAGGCAGGAGGGGGAGGGGA+6.16
ZNF263MA0528.1chr7:2121799-2121820GAGGCAGGAGGGGGAGGGGAC+6.26
ZNF263MA0528.1chr7:2121904-2121925GAGGGAGGGAAGGGAAGGAGA+7.1
ZNF263MA0528.1chr7:2121900-2121921GAAGGAGGGAGGGAAGGGAAG+8.05
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr721223402122475
Number: 1             
IDChromosomeStartEnd
GH07I002081chr721213212123185
Enhancer Sequence
ATTAGGAGAG AGGTTGGAGC CAAAGATAGA GACTCTGAAG TCTGGCCACA CTGAAGTGAC 60
AAGAAGAGAT GTCAAAGCAC AAGAACTTAT GTAAGAAGGA AAAGCAGAGA CCGAGGAATA 120
AAGAACGGAG AACAAGCTCC CGGGAACACC TGCGCAGGAG ATGCCAGAGA AAGGGAAGGG 180
AGGCAGGAGG GGGAGGGGAC GGGGACCAGG AGGCCATGTG TGAGTGTGAG GGGGCTGTGC 240
ACATCCCACA ACAGCTGCAC GGGAAACCAG AAAAGCCAGG GAAGGAGGGA GGGAAGGGAA 300
GGAGAGCGGG GACCATGGGG CCGTGTGTGA GACAGAGTGC AGGAGGGAGA AGGGAGAGAG 360
CGGGAGAGAC AGGAGGGAAG GAGCCAGGCC TGGGGAGCTC AGCAAGGGAG ATGGGAGAGA 420
CAGAAGGAGA GACCAGAGGG AAGGAGCCGG GCCTGGGAGC TCAGCGGAGC TGCTGTCGGA 480
GCCGTGACTT CAGCACCATG TGGCCAGTGA ATCAGAGCCG TGAGGCATGG AGCTGGGCTC 540
TGGCCGGCGT CGCCGGGTCT GGTGTGGGAG TGCAGCACTC TAGAGAGGCA GCAGGCCAAG 600
TGGAAGGACC AGGCTGAGGA GATTGAGCTC TGAGGATCAA GGGGCTCACA TACCCCGTTT 660
AACTGAGGCT TGCATCAAAT TAGACAAATA GTTAAAAGAA GAGGCAAAGC GATCTCTGTG 720
GCGTCTCTCT TTGGAATCAC CCGATAGCCC AATTAGCAGC TCTGAAGCTG AGGCTCTAGT 780
GCCCATGACA ATTGATGGAG CCCGGCGCCT GCACTCGGCC CAGCCTCCGC CCACGCCTGT 840
GCGCCGCACG ACCACTCCAG CTGCTTCAGC GCTACCTGGG TAATGAAGCA CATTCGGCCT 900
GTTTATTTTC CCATTGATTT TGCCATCCTT 930